your market intelligence analyst
Search Results
26 results
Your search is now limited to «Drugs» expert search.
GlobeNewswire 10/17/2019 09:48
Assuming FDA approval, Vascepa is positioned to become the first drug indicated to reduce persistent residual cardiovascular risk in statin-managed patients with elevated triglycerides (135 mg/dL or greater) and other risk factors for cardiovascular disease.

Personal Care

Household Products

Business Issues


Companies - Public

Companies - Venture Funded

Information Technologies


Job Titles